Masahiro Tabata

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.

Journal: Molecular oncology

Published: October 07, 2025

Pazopanib therapy for children, adolescents, and young adults with relapsed and refractory sarcomas.

Pazopanib therapy for children, adolescents, and young adults with relapsed and refractory sarcomas.

Journal: Japanese journal of clinical oncology

Published: August 24, 2025

Intracardiac Echocardiography-Guided Biopsy for a Giant Cardiac Angiosarcoma with Extensive Invasion.

Intracardiac Echocardiography-Guided Biopsy for a Giant Cardiac Angiosarcoma with Extensive Invasion.

Journal: International heart journal

Published: July 30, 2025

Remarkable Efficacy of Capmatinib in a Patient with Cancer of Unknown Primary with MET Amplification.

Remarkable Efficacy of Capmatinib in a Patient with Cancer of Unknown Primary with MET Amplification.

Journal: Internal medicine (Tokyo, Japan)

Published: May 21, 2025

A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion.

A Prompt Diagnosis of Ascites and Dramatic Effect of Alectinib for Advanced Lung Adenocarcinoma Harboring EML4-ALK Fusion.

Journal: Internal medicine (Tokyo, Japan)

Published: May 21, 2025

Real-World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in Sarcoma.

Real-World Data of Comprehensive Cancer Genomic Profiling Tests Performed in the Routine Clinical Setting in Sarcoma.

Journal: Cancer medicine

Published: April 12, 2025

Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation.

Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation.

Journal: Molecular cancer therapeutics

Published: January 19, 2025

Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines.

Efficacy of amivantamab, a bi-specific antibody targeting EGFR and MET, in ALK-rearranged non-small-cell lung cancer cell lines.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 22, 2024

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

Journal: Scientific reports

Published: October 25, 2024

Cancer-related alopecia and wig acquisition: how age, sex, and treatment affect patient choices.

Cancer-related alopecia and wig acquisition: how age, sex, and treatment affect patient choices.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: September 30, 2024

Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report.

Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report.

Journal: JCO precision oncology

Published: September 19, 2024

Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension.

Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension.

Journal: Internal medicine (Tokyo, Japan)

Published: September 11, 2024

Showing 1-12 of 95

Last Updated: 09/26/2026